CTHRC1, or Collagen Triple Helix Repeat Containing 1, has been shown to play various roles in the development and progression of cancer. Studies have indicated that CTHRC1 is overexpressed in several types of cancer, including breast, colorectal, and liver cancer, and its upregulation is associated with increased tumor growth, invasion, and metastasis. CTHRC1 has been implicated in promoting cancer cell migration, angiogenesis, and resistance to chemotherapy, making it a potential target for cancer therapy. Additionally, CTHRC1 has been suggested to have a role in regulating the tumor microenvironment and modulating the immune response in cancer. Further research is needed to fully understand the mechanisms by which CTHRC1 contributes to cancer progression and how it can be targeted for therapeutic purposes.
This mind map was published on 20 February 2024 and has been viewed 100 times.